118 related articles for article (PubMed ID: 25679398)
1. Serum proteomic changes after randomized prolonged erythropoietin treatment and/or endurance training: detection of novel biomarkers.
Christensen B; Ludvigsen M; Nellemann B; Kopchick JJ; Honoré B; Jørgensen JO
PLoS One; 2015; 10(2):e0117119. PubMed ID: 25679398
[TBL] [Abstract][Full Text] [Related]
2. Comparative Effects of Aerobic Training and Erythropoietin on Oxygen Uptake in Untrained Humans.
Sieljacks P; Thams L; Nellemann B; Larsen MS; Vissing K; Christensen B
J Strength Cond Res; 2016 Aug; 30(8):2307-17. PubMed ID: 26694499
[TBL] [Abstract][Full Text] [Related]
3. Whole body metabolic effects of prolonged endurance training in combination with erythropoietin treatment in humans: a randomized placebo controlled trial.
Christensen B; Nellemann B; Larsen MS; Thams L; Sieljacks P; Vestergaard PF; Bibby BM; Vissing K; Stødkilde-Jørgensen H; Pedersen SB; Møller N; Nielsen S; Jessen N; Jørgensen JO
Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E879-89. PubMed ID: 23921143
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin administration alone or in combination with endurance training affects neither skeletal muscle morphology nor angiogenesis in healthy young men.
Larsen MS; Vissing K; Thams L; Sieljacks P; Dalgas U; Nellemann B; Christensen B
Exp Physiol; 2014 Oct; 99(10):1409-20. PubMed ID: 25128327
[TBL] [Abstract][Full Text] [Related]
5. Satellite cell response to erythropoietin treatment and endurance training in healthy young men.
Hoedt A; Christensen B; Nellemann B; Mikkelsen UR; Hansen M; Schjerling P; Farup J
J Physiol; 2016 Feb; 594(3):727-43. PubMed ID: 26607845
[TBL] [Abstract][Full Text] [Related]
6. Applications of darbepoietin-alpha, a novel erythropoiesis-stimulating protein, in oncology.
Smith R
Curr Opin Hematol; 2002 May; 9(3):228-33. PubMed ID: 11953669
[TBL] [Abstract][Full Text] [Related]
7. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
[TBL] [Abstract][Full Text] [Related]
8. A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit.
Brophy GM; Sheehan V; Shapiro MJ; Lottenberg L; Scarlata D; Audhya P;
Clin Ther; 2008 Dec; 30(12):2324-34. PubMed ID: 19167591
[TBL] [Abstract][Full Text] [Related]
9. Novel serum biomarkers for erythropoietin use in humans: a proteomic approach.
Christensen B; Sackmann-Sala L; Cruz-Topete D; Jørgensen JO; Jessen N; Lundby C; Kopchick JJ
J Appl Physiol (1985); 2011 Jan; 110(1):149-56. PubMed ID: 20966191
[TBL] [Abstract][Full Text] [Related]
10. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of haptoglobin and serum amyloid A proteins as biomarkers for atherothrombotic ischemic stroke diagnosis confirmation.
Brea D; Sobrino T; Blanco M; Fraga M; Agulla J; Rodríguez-Yáñez M; Rodríguez-González R; Pérez de la Ossa N; Leira R; Forteza J; Dávalos A; Castillo J
Atherosclerosis; 2009 Aug; 205(2):561-7. PubMed ID: 19171342
[TBL] [Abstract][Full Text] [Related]
12. Proteomic identification of serum biomarkers for gastric cancer using multi-dimensional liquid chromatography and 2D differential gel electrophoresis.
Liu W; Liu B; Cai Q; Li J; Chen X; Zhu Z
Clin Chim Acta; 2012 Jul; 413(13-14):1098-106. PubMed ID: 22446497
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
14. Exercise training and intensity does not alter vascular volume responses in women.
Branch JD; Pate RR; Bourque SP; Convertino VA; Durstine JL; Ward DS
Aviat Space Environ Med; 1999 Nov; 70(11):1070-6. PubMed ID: 10608603
[TBL] [Abstract][Full Text] [Related]
15. Identification of the long-acting erythropoiesis-stimulating agent darbepoetin alfa in human urine by liquid chromatography-tandem mass spectrometry.
Okano M; Sato M; Kageyama S
Anal Bioanal Chem; 2014 Feb; 406(5):1317-29. PubMed ID: 23443522
[TBL] [Abstract][Full Text] [Related]
16. Differentially expressed serum haptoglobin alpha chain isoforms with potential application for diagnosis of head and neck cancer.
Chen CB; Su YC; Huang TT; Ho HC; Chang YT; Tung YT; Lee WC
Clin Chim Acta; 2008 Dec; 398(1-2):48-52. PubMed ID: 18727923
[TBL] [Abstract][Full Text] [Related]
17. Proteomic profiling of k-11706 responsive proteins.
Horie M; Kawashima Y; Naka A; Matsumoto K; Kodera Y; Maeda T; Iida K
Int J Sports Med; 2011 Jul; 32(7):559-64. PubMed ID: 21567354
[TBL] [Abstract][Full Text] [Related]
18. Haptoglobin-α1, -α2, vitamin D-binding protein and apolipoprotein C-III as predictors of etanercept drug response in rheumatoid arthritis.
Blaschke S; Rinke K; Maring M; Flad T; Patschan S; Jahn O; Mueller CA; Mueller GA; Dihazi H
Arthritis Res Ther; 2015 Mar; 17(1):45. PubMed ID: 25884688
[TBL] [Abstract][Full Text] [Related]
19. Proteomics profiling of swine serum following lipopolysaccharide stimulation.
Olumee-Shabon Z; Chattopadhaya C; Myers MJ
Rapid Commun Mass Spectrom; 2020 Apr; 34(7):e8639. PubMed ID: 31659824
[TBL] [Abstract][Full Text] [Related]
20. Plasma proteins as early biomarkers of exposure to carcinogenic aromatic amines.
Miller MJ; Parmelee DC; Benjamin T; Sechi S; Dooley KL; Kadlubar FF
Chem Biol Interact; 1994 Dec; 93(3):221-34. PubMed ID: 7923441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
